What is McCreadie Group?
McCreadie Group operates at the intersection of healthcare technology and operational management, providing critical infrastructure for clinical research sites and academic medical centers. Their flagship platform, Vestigo, serves as a comprehensive site-enablement tool designed to streamline the intricacies of clinical trials. By addressing the operational bottlenecks faced by sponsors and research associates, the company enhances compliance and workflow efficiency. The firm's focus on pharmacy education and investigational drug operations positions it as a vital partner for institutions aiming to modernize their research administration and residency program management.
How much funding has McCreadie Group raised?
McCreadie Group has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in McCreadie Group
PPP
Public-Private Partnership
What's next for McCreadie Group?
With this late-stage financing, McCreadie Group is well-positioned to accelerate its product development roadmap and expand its footprint in the clinical research sector. The strategic allocation of this capital will likely focus on enhancing the scalability of the Vestigo platform, ensuring it meets the evolving regulatory and operational demands of global clinical trials. As the company transitions into this next phase of growth, the focus will remain on deepening its integration within academic medical centers and broadening its service offerings to support the increasing complexity of investigational drug management. This investment serves as a catalyst for long-term market leadership in the niche of clinical research site enablement.
See full McCreadie Group company page
